Explore answers to our most commonly asked questions about CBD, our products, and more.
Researchers typically study CJC-1295 with DAC for its effect on the GH/IGF-1 axis and for sustained stimulation of endogenous growth-hormone release. In FAQ copy, the useful distinction is that it is designed for longer activity than non-DAC versions, which affects how researchers think about pulse pattern and study timing.
CJC-1295 with DAC is a long-acting analog of growth hormone-releasing hormone. The DAC portion refers to a drug-affinity complex added to prolong circulation time, which is why it is usually distinguished from shorter-acting GHRH analogs. It should be presented as a research peptide for endocrine signaling studies only.
Our agents are here to help you.
